Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 50 of 1088 Next >>

Filter Applied: prognosis (Click to remove)

Ophthalmic Manifestations of Giant Cell Arteritis
Rheumatology 57:ii63-1172, Vodopivec, I. & Rizzo, J.F. III, 2018

Prevalence and Distribution of VZV in Temporal Arteries of Patients with Giant Cell
Neurol 84:1948-1955, Gilden, D.,et al, 2015

Ischemic Optic Neuropathies
NEJM 372:2428-2436, Biousse, V. & Newman, N.J., 2015

Giant-Cell Arteritis and Polymyalgia Rheumatica
NEJM 371:50-57, Weyand, C.M. & Goronzy J.J., 2014

Polymyalgia Rheumatica
Lancet 381:63-72, Kermani, T. & Washington, K., 2013

Strokes at Time of Disease Diagnosis in a Series of 287 Patients with Biopsy-Proven Giant Cell Arteritis
Medicine 88:227-235, Gonzalez-Gay,M.A.,et al, 2009

Polymyalgia Rheumatica
BMJ 336:765-769, Michet,C.J. &Matteson,E.L., 2008

Polymyalgia Rheumatica and Giant-Cell Arteritis
Lancet 372:234-245, Salvarani,C.,et al., 2008

A 63-Year-Old Man With Headaches and Behavioral Deterioration
Neurol 68:782-787, Greenberg,S.M.,et al, 2007

Primary Central Nervous System Vasculitis: Analysis of 101 Patients
Ann Neurol 62:442-451,430, Salvarani,C.,et al, 2007

Bilateral Vertebral Artery Occlusion Resulting from Giant Cell Arteritis: Report of 3 Cases and Review of the Literature
Medicine 82:1-12, Ruegg,S.,et al, 2003

Prognosis of Patients with Suspected Primary CNS Angiitis and Negative Brain Biopsy
Neurol 61:831-833, Alreshaid,A.A.&Powers,W.J., 2003

Polymyalgia Rheumatica and Giant-Cell Arteritis
NEJM 347:261-271, Salvarani,C.,et al, 2002

Angiotropic Large Cell Lymphoma with Imaging Characteristics of CNS Vasculitis
AJNR 23:239-242, Song,D.K.,et al, 2002

Clinical Spectrum of Posterior Ischemic Optic Neuropathy
Am J Ophthalmol 132:743-750, Sadda,S.R.,et al, 2001

Angiographically Defined Primary Angiitis of the CNS, Is It Really Benign
Neurol 51:183-188, Woolfenden,A.R.,et al, 1998

Primary Angiitis of the Central Nervous System:Report of Two Cases and Review of the Literature
Neurosurg 36:173-179, Ozawa,T.,et al, 1995

Visual Morbidity in Giant Cell Arteritis:Clinical Characteristics and Prognosis for Vision
Ophthalmology 101:1779-1785, Liu,G.T.,et al, 1994

Presenting Features and Outcomes in Patients Undergoing Temporal Artery Biopsy, Review of 98 Pts
Arch Int Med 152:1690-1695, Chmelewski,W.L.,et al, 1992

Clinical Analysis of Isolated Angiitis of the Central Nervous System, A Report of 11 Cases
Arch Int Med 151:2290-2294, Crane,R.,et al, 1991

Stopping Steroids in Polymyalgia Rheumatica and Giant Cell Arteritis
BMJ 300:344-345, Kyle,V.&Hazelman,B.L., 1990

Neurologic Manifestations of Giant Cell Arteritis
Am J Med 89:67-72, Reich,K.A.,et al, 1990

Diagnosis and Management of Isolated Angiitis of the Central Nervous System
Neurol 39:167-173, Moore,P.M., 1989

Death Rates and Causes of Death in 284 Consecutive Patients with Giant Cell Arteritis Confirmed by Biopsy
BMJ 299:549-550, Nordborg,E.&Bengtsson,B.A., 1989

Prognosis in Giant-cell Arteritis
BMJ 282:269-270, Graham,E.,et al, 1981

Overview of IgG4-related Disease
UptoDate, July, Moutsopoulos,H.,et al, 2017

Mycoplasma Pneumoniae Infection: Neurologic Complications
www.MedLink.com, Oct, Greenlee, J.E., 2013

Clinical Profile of Simultaneous Bilateral Optic Neuritis in Adults
Br J Ophthalmol 90:551-554, De la Cruz, J. & Kupersmith, M.J., 2006

Churg-Strauss Syndrome, Clinical Study and Long-Term Follow-Up of 96 Patients
Medicine 78:26-37, Guillevin,L.,et al, 1999

Clinicopath Conf
Rocky Mountain Spotted Fever with Meningoencephalomyelitis, Vasculitis and Focal Myocarditis, Case 3, -17,NEJM 337:1149-1156,1997., 1997

Centrofacial Malignant Granulomas, Clinicopath Study of 40 Cases and Review of the Literature
Medicine 71:179-195, Grange,C.,et al, 1992

Diagnosis and Management of ANCA-Associated Vasculitis
Lancet 403:683-698, Kronbichler, A., et al, 2024

Clinical,Neuroimaging,and Genetic Markers in Cerebral Amyloid Angiopatny-Related Inflammation:A Systematic Review and Meta-Analusis
Stroke 54:178-188, Theodorou,A.,et al, 2023

Characteristics of Progressive Multifocal Leukoencephalopathy Associated with Sarcoidosis without Therapeutic Immune Suppression
JAMA Neurol 80:624-633, McEntire,C.R.S.,et al, 2023

Congenital Cytomegalovirus Infection
BMJ 373:m1212, Pesch, M.H.,et al, 2021

The Tolosa-Hunt Syndrome
NJJP 71:577-582, Kline,L.B. & Hoyt,W.F., 2021

Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020

Spontaneous Intracranial Hypotension: Atypical Radiologic Appearances, Imaging Mimickers, and Clinical Look-Alikes
AJNR 41:1339-1347, Bond, K.M.,et al, 2020

Central Nervous System Involvement in Erdheim-Chester Disease
Neurol 95:e2746-e2754, Aubart,F.C.,et al, 2020

Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis
Neurol 95:e3012-e3025, Spatola, M.,et al, 2020

Stridor in Multiple System Atrophy
Neurol 93:630-639, Cortelli, P.,et al, 2019

Cerebrovascular Manifestations of Herpes Simplex Virus Infection of the Central Nervous System: A Systematic Review
J Neruoinflam 16:19, Hauer,L.,et al, 2019

Hereditary Spastic Paraplegia:From Diagnosis to Emerging Therapeutic Approaches
Lancet Neurol 18:1136-1146, Shribman,S.,et al, 2019

Immune Checkpoint Inhibitor-Related Myositis and Myocarditis in Patients with Cancer
Neurol 91:e985-e994, Touat, M.,et al, 2018

Behcet Disease
emedicine.medscape.com Dec, Davey-Ranasinghe, N. & Diamond, H.S., 2018

Infliximab for the Treatment of CNS Sarcoidosis
Neurol 89:2092-2100, Gelfand, J.M.,et al, 2017

Antibiotic-Associated Encephalopathy
Neurol 86:963-971, Bhattacharyya, S.,et al, 2016

Fat Embolism Syndrome Secondary to Bone Marrow Necrosis in Patients with Hemoglobinopathies
SMJ 109:549-553, Gangaraju, R.,et al, 2016

The Spectrum of Acute Encephalitis
Neurol 84:359-366, Singh, T.D.,et al, 2015



Showing articles 0 to 50 of 1088 Next >>